CD9 and prostate carcinoma: Likewise, CD9 was present with the strongest signals within the overall analyzed EV proteins and increasing signals from the healthy control PNT1A to the prostate cancer cell lines 22Rv1, LNCaP to PC3 (Fig. 3C).